Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07122349) titled 'Cannabis Impairment Detection Device Study' on Aug. 6.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Screening. Masking: None (Open Label).

Primary Sponsor: Gaize

Condition: Cannabis Intoxication

Intervention: Device: Cannabis Impairment Test

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: September 8, 2022

Target Sample Size: 362

Countries of Recruitment: Canada

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07122349

Published by HT Digital Content Services with permission from Health Daily ...